SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy-Reference-Cited by-同舟云学术

SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy

Published:2013-04-02 Issue:4 Volume:8 Page:e60113
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kobayashi Dione T.,Shi Jing,Stephen Laurie,Ballard Karri L.,Dewey Ruth,Mapes James,Chung Brett,McCarthy Kathleen,Swoboda Kathryn J.,Crawford Thomas O.,Li Rebecca,Plasterer Thomas,Joyce Cynthia,Chung Wendy K.,Kaufmann Petra,Darras Basil T.,Finkel Richard S.,Sproule Douglas M.,Martens William B.,McDermott Michael P.,De Vivo Darryl C.,Walker Michael G.,Chen Karen S., ,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference77 articles.

1. Progress and promise: the current status of spinal muscular atrophy therapeutics;JP Van Meerbeke;Discov Med,2011

2. SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy;JT Kissel;PLoS One,2011

3. Pilot trial of phenylbutyrate in spinal muscular atrophy;E Mercuri;Neuromuscul Disord,2004

4. Daily salbutamol in young patients with SMA type II;M Pane;Neuromuscul Disord,2008

5. Phase II open label study of valproic acid in spinal muscular atrophy;KJ Swoboda;PLoS One,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuromuscular disorders in the omics era;Clinica Chimica Acta;2024-01

2. Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy;Journal of Clinical Medicine;2023-08-01

3. Biomarkers in 5q-associated spinal muscular atrophy—a narrative review;Journal of Neurology;2023-06-08

4. Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency;Communications Biology;2023-05-25

5. Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples;Biomedicines;2023-04-23